Nuo Therapeutics AURX Cash Flow Statement (2010-2026)

OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT
Reported Financials

Nuo Therapeutics Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Nuo Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-0.01M-0.01M-0.07M-0.38M-0.92M-0.91M-0.96M-0.86M-0.87M-0.79M-0.65M-0.71M-0.54M-0.58M-0.50M-0.75M-0.65M-0.54M-0.58M-0.28M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.02M0.02M0.02M0.03M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.02M0.02M0.02M0.03M
Share-based CompensationStock Comp.
0.01M0.00M0.00M197.000.00M0.00M0.01M0.00M0.00M0.00M0.02M0.03M0.02M0.02M0.02M0.02M0.04M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.03M0.01M0.01M
Other non-cash itemsOther Non-Cash
0.15M0.02M0.02M0.02M0.02M0.02M0.10M0.08M0.04M0.02M0.02M-0.05M0.03M0.05M0.07M
Change in Working Capital
Change in ReceivablesChange Receivables
0.03M0.06M0.04M0.07M0.13M0.08M0.00M0.08M0.02M-0.02M0.04M0.04M0.36M-0.04M
Change in InventoryChange Inventory
0.09M0.14M0.03M-0.02M-0.03M0.01M-70.00-71.000.00M0.01M-0.02M-0.02M-0.04M0.07M0.04M0.02M
Change in Account PayablesChange Payables
0.00M0.00M612.000.04M-0.03M-0.06M0.06M0.03M0.01M-0.04M-0.01M0.09M-0.09M-0.01M-0.03M0.44M-0.35M0.18M-0.06M
Change in Accured ExpensesChange Accured Exp.
-0.01M-0.01M0.01M0.10M0.02M0.04M0.01M-0.01M0.03M0.02M0.03M0.03M0.06M-0.04M0.08M0.10M
Change in Other Operating AssetsOther Assets Change
0.00M0.05M0.15M-0.01M0.02M-0.01M-0.02M0.02M-0.01M0.00M-756.000.01M-0.02M0.00M0.01M-0.12M0.04M-0.04M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M-0.06M581.00-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.01M-0.01M-0.02M0.18M1.21M-0.09M-0.09M
Other Working Capital ChangesOther WC Changes
0.00M-0.05M-0.16M-0.05M-0.02M-0.01M-295.00-0.03M-0.01M-0.02M-0.02M-0.02M0.00M-0.01M0.17M1.33M-0.14M-0.05M
Cash from OperationsCash from Ops.
-0.01M0.00M-0.11M-0.74M-1.14M-1.01M-0.82M-0.80M-0.91M-0.79M-0.67M-0.56M-0.69M-0.49M-0.49M0.00M0.26M-0.71M-0.42M
Investing Activities
Capital ExpendituresCapex
0.01M0.04M0.00M0.00M0.01M0.00M0.00M0.15M0.23M0.00M0.04M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.04M0.00M0.00M-0.01M0.00M0.00M-0.15M-0.23M0.00M-0.04M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.01M-0.04M0.00M0.00M-0.01M0.00M0.00M-0.15M-0.23M0.00M-0.04M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Short-Term Debt issuancesST Debt Issuance
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
1.37M3.96M1.04M0.96M0.85M0.09M0.90M
Net Shares Issued and RepurchasedNet Shares Issued
1.37M3.96M1.04M0.96M0.85M0.09M0.90M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
1.37M3.96M1.04M0.96M0.85M0.09M0.90M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
Dividends Paid - Common and PrefferdDiv Paid (Total)
Cash from Financing ActivitiesCash from Financing
1.37M3.96M0.50M1.04M0.96M0.80M0.85M0.09M0.90M0.50M
Additional items
Change in Cash
-0.01M0.00M1.27M-0.75M2.78M-0.51M-0.83M-0.80M-0.91M0.24M0.29M-0.56M0.11M0.21M-0.40M-0.23M0.26M0.20M0.03M
Ending Cash Balance
0.15M0.15M1.41M0.67M3.44M2.93M2.11M1.31M0.40M0.64M0.93M0.37M0.47M0.68M0.28M0.10M0.32M0.51M0.55M0.45M
Free Cash FlowFCF
-0.01M0.00M-0.11M-0.75M-1.18M-1.01M-0.83M-0.80M-0.91M-0.80M-0.67M-0.56M-0.70M-0.64M-0.49M-0.23M0.26M-0.71M-0.47M
Net Cash FlowNCF
-0.01M0.00M1.27M-0.75M2.78M-0.51M-0.83M-0.80M-0.91M0.24M0.29M-0.56M0.11M0.21M-0.40M-0.23M0.26M0.20M0.03M
Interest Paid
324.000.00M741.00670.00701.000.00M0.00M474.000.00M0.00M0.00M612.000.00M0.00M

Nuo Therapeutics Cash Flow Statement API

Pull Nuo Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AURX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY